CELEX: 32022M10611
Language: en
Date: 2022-03-23 00:00:00
Title: Commission Decision of 23/03/2022 declaring a concentration to be compatible with the common market (Case No COMP/M.10611 - GENERALI FRANCE / LA MÉDICALE) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION
                                                                 Brussels, 23.3.2022
                                                                 C(2022) 1922 final
                                                                                 PUBLIC VERSION
                                                                 Generali France
                                                                 2 rue Pillet-Will
                                                                 75009 Paris
                                                                 France
Subject:        Case M.10611 -GENERALI FRANCE / LA MÉDICALE
                Commission decision pursuant to Article 6(1)(b) of Council Regulation
                (EC) No 139/20041 and Article 57 of the Agreement on the European
                Economic Area2
Dear Sir or Madam,
1.      On 28 February 2022, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which Generali
        France S.A. (“Generali France”, France), belonging to the Generali Group, ultimately
        controlled by Assicurazioni Generali S.p.A. (Italy), acquires within the meaning of
        Article 3(1)(b) of the Merger Regulation control of the whole of La Médicale S.A.
        (‘La Medicale’, France), controlled by Crédit Agricole S.A. (‘Credit Agricole’,
        France) and of a portfolio of death covers and irreversible loss of autonomy covers
        insured by Predica Prévoyance Dialogue du Crédit Agricole S.A., a subsidiary of
        Crédit Agricole S.A., and marketed by La Médicale (the ‘Insurance Portfolio’). The
        concentration is accomplished by way of purchase of shares and assets.3
2.      The business activities of the undertakings concerned are the following:
             Generali France is part of the Generali Group, an international group of
              companies active in the insurance and financial sector across the world. Generali
              France provides and distributes both life and non-life insurance products,
             La Médicale is a French specialist insurer for healthcare professionals active in
              France and Monaco. It provides non-life insurance products and focuses on
              medical liability insurance. La Médicale offers a number of additional products,
1       OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on
        the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the
        replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology
        of the TFEU will be used throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’).
3       Publication in the Official Journal of the European Union No C 111, 08.03.2022, p. 5.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
 ---pagebreak---         such as personal injuries, motor vehicle, property, liability, and legal insurance.
        La Médicale currently markets the Insurance Portfolio and the Insurance Portfolio
        will also be part of the acquisition carried out by Generali France.
3. After examination of the notification, the European Commission has concluded that
   the notified operation falls within the scope of the Merger Regulation and of
   paragraph 5(c) of the Commission Notice on a simplified procedure for treatment of
   certain concentrations under Council Regulation (EC) No 139/2004.4
4. For the reasons set out in the Notice on a simplified procedure, the European
   Commission has decided not to oppose the notified operation and to declare it
   compatible with the internal market and with the EEA Agreement. This decision is
   adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of
   the EEA Agreement.
                                                      For the Commission
                                                      (Signed)
                                                      Olivier GUERSENT
                                                      Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                                 2